PILA — Pila Pharma AB Cashflow Statement
0.000.00%
- SEK86.53m
- SEK81.64m
- SEK0.77m
Annual cashflow statement for Pila Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | Interim Report | PRESS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.98 | -17.2 | -26.8 | -9.93 | -11.2 |
Non-Cash Items | 3.62 | 7.94 | 17.9 | 4.57 | 4.16 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.36 | -0.093 | -0.216 | 0.502 | -0.739 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2 | -9.36 | -9.09 | -4.85 | -7.82 |
Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Items | -3.6 | -7.92 | -17.9 | -3.5 | -3.08 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.158 | 35.7 | -11.9 | 3.56 | 6.76 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.16 | 26.3 | -21 | -1.29 | -1.06 |